South Korea mRNA Synthesis & Manufacturing Market (2024-2029)
The South Korea mRNA Synthesis & Manufacturing Market was valued at $33.05 Million in 2024 and projected to reach to $44.08 Million by 2029, representing a compound annual growth rate of 5.9%. South Korea's mRNA synthesis and manufacturing market is poised for sustained expansion through 2029, driven by increasing investments in personalized medicine, vaccine development, and therapeutic applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea mRNA Synthesis & Manufacturing Market Trends and Insights
- South Korea has emerged as a key player in the Asia Pacific region, leveraging its advanced biotechnology infrastructure and government support for life sciences innovation.
- The market in South Korea is driven by increasing investments in vaccine development, therapeutic mRNA platforms, and contract manufacturing capabilities that position the country as a regional hub for mRNA production. The forecast period through 2029 reflects South Korea's commitment to strengthening its biopharmaceutical ecosystem and competing in the global mRNA space.
- South Korea's growth trajectory at 5.9% CAGR outpaces several global markets, supported by domestic pharmaceutical companies and international partnerships.
- South Korea continues to attract foreign investment and collaboration agreements, particularly from multinational biotech firms seeking manufacturing and development partners in Asia Pacific..
Key Market Statistics
- CAGR (2024-2029) 5.9% CAGR
- Market Size, 2024 ~USD 33.05 Million
- Forecast, 2029 ~USD 44.08 Million
- Country South Korea
South Korea mRNA Synthesis & Manufacturing Market Overview
Market Valuation & Growth :
South Korea's mRNA synthesis and manufacturing market is valued at $33.05 million in 2024, with a projected CAGR of 5.9% through 2029, reaching $44.08 million by forecast end.
Advanced Biotechnology Infrastructure :
South Korea possesses world-class biotech facilities and manufacturing capabilities, positioning it as a critical hub for mRNA production in the Asia Pacific region alongside established pharmaceutical manufacturing expertise.
Government Support & Innovation :
Strong government backing for life sciences innovation and R&D investments in South Korea accelerates mRNA technology adoption and attracts both domestic and international biotech companies to establish operations.
Regional Market Leadership :
South Korea has emerged as a key player in Asia Pacific mRNA markets, leveraging its skilled workforce, regulatory framework, and strategic partnerships to capture growing demand for mRNA therapeutics and vaccines.
South Korea mRNA Synthesis & Manufacturing Market Dynamics
- The country's commitment to biotechnology innovation, combined with government incentives and private sector collaboration, creates a favorable environment for market growth.
- South Korea's strategic position in Asia Pacific, coupled with its advanced manufacturing capabilities and skilled scientific workforce, positions it as an attractive destination for mRNA production and research initiatives.
- Continued expansion of manufacturing facilities and partnerships with global pharmaceutical companies will further strengthen South Korea's market presence and competitiveness in the global mRNA landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- South Korea's mRNA synthesis market is valued at $33.05 million in 2024, with projected growth to $44.08 million by 2029.
- South Korea demonstrates a 5.9% CAGR, reflecting strong regional demand and government biotech investment initiatives.
- South Korea is positioning itself as a contract manufacturing hub for mRNA therapeutics and vaccines in Asia Pacific.
- South Korea's advanced infrastructure and skilled workforce support competitive advantages in mRNA platform development and scale-up.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
South Korea mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
Target Audience
- Pharmaceutical & Biotech Companies : Manufacturers and developers seeking to establish or expand mRNA production capabilities in South Korea need market sizing, competitive analysis, and regulatory guidance specific to this strategic Asia Pacific location.
- Investment & Private Equity Firms : Investors evaluating opportunities in South Korea's biotech sector require detailed market forecasts, growth drivers, and competitive positioning data to make informed investment decisions and identify acquisition targets.
- Government & Policy Makers : South Korean government agencies and policy makers need market intelligence to refine life sciences strategies, allocate R&D funding, and develop competitive advantages in the global mRNA manufacturing landscape.
- Contract Manufacturing Organizations (CMOs) : CMOs and service providers require South Korea-specific market data to assess demand for mRNA manufacturing services, identify client opportunities, and plan capacity expansion in this growing market.
- Healthcare & Research Institutions : Academic medical centers and research institutions in South Korea need market insights to guide mRNA research initiatives, secure funding, and establish collaborations with commercial partners.
Reasons to Buy this Report
- Market-Specific Growth Projections : Access detailed South Korea-specific forecasts showing 5.9% CAGR growth from $33.05M to $44.08M by 2029, enabling precise investment and expansion planning in this high-potential market.
- Competitive Landscape Intelligence : Understand South Korea's unique position as an Asia Pacific leader in mRNA manufacturing, identifying key competitors, market consolidation trends, and opportunities for market entry or partnership.
- Government Policy & Regulatory Insights : Gain comprehensive understanding of South Korea's government support mechanisms, regulatory framework, and life sciences innovation incentives that drive market dynamics and investment opportunities.
- Infrastructure & Capacity Analysis : Evaluate South Korea's advanced biotechnology infrastructure, manufacturing capabilities, and facility expansion plans to assess production capacity and identify partnership or acquisition opportunities.
- Strategic Market Entry Planning : Leverage South Korea-specific data to develop targeted market entry strategies, identify local partnerships, and capitalize on the country's skilled workforce and favorable business environment.
Frequently asked questions
What is the current market size of mRNA synthesis and manufacturing in South Korea?
South Korea's mRNA synthesis and manufacturing market was valued at $33.05 million in 2024 and is expected to grow to $44.08 million by 2029.
What is the projected growth rate for South Korea's mRNA market?
South Korea's mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2029.
Why is South Korea becoming important in mRNA manufacturing?
South Korea possesses advanced biotechnology infrastructure, government support for life sciences, skilled workforce, and strategic partnerships that position it as a regional manufacturing and development hub for mRNA therapeutics.
What are the main drivers of growth in South Korea's mRNA market?
Key drivers include increased vaccine development initiatives, therapeutic mRNA platform expansion, contract manufacturing opportunities, and foreign investment in South Korea's biopharmaceutical sector.
How does South Korea's mRNA market growth compare to global trends?
South Korea's 5.9% CAGR is competitive within the Asia Pacific region and reflects strong regional momentum, supported by domestic innovation and international collaboration in mRNA technologies.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
